# Preoperative Panitumumab and Radiotherapy in Rectal Cancer

> **NCT00973193** · PHASE2 · TERMINATED · sponsor: **Cliniques universitaires Saint-Luc- Université Catholique de Louvain** · enrollment: 20 (actual)

## Conditions studied

- Rectal Cancer

## Interventions

- **DRUG:** panitumumab

## Key facts

- **NCT ID:** NCT00973193
- **Lead sponsor:** Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-09
- **Primary completion:** 2011-09
- **Final completion:** 2012-12
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** The intermediate analyses did not allowed to continue the clinical study.
- **Last updated:** 2016-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00973193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00973193, "Preoperative Panitumumab and Radiotherapy in Rectal Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00973193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*